Cargando…

Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe

BACKGROUND: Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but extremely severe cutaneous adverse drug reactions in which drug-specific associations with HLA-B alleles were described. OBJECTIVES: To investigate genetic association at a genome-wide level on a large sampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Génin, Emmanuelle, Schumacher, Martin, Roujeau, Jean-Claude, Naldi, Luigi, Liss, Yvonne, Kazma, Rémi, Sekula, Peggy, Hovnanian, Alain, Mockenhaupt, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173287/
https://www.ncbi.nlm.nih.gov/pubmed/21801394
http://dx.doi.org/10.1186/1750-1172-6-52
_version_ 1782211939893510144
author Génin, Emmanuelle
Schumacher, Martin
Roujeau, Jean-Claude
Naldi, Luigi
Liss, Yvonne
Kazma, Rémi
Sekula, Peggy
Hovnanian, Alain
Mockenhaupt, Maja
author_facet Génin, Emmanuelle
Schumacher, Martin
Roujeau, Jean-Claude
Naldi, Luigi
Liss, Yvonne
Kazma, Rémi
Sekula, Peggy
Hovnanian, Alain
Mockenhaupt, Maja
author_sort Génin, Emmanuelle
collection PubMed
description BACKGROUND: Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but extremely severe cutaneous adverse drug reactions in which drug-specific associations with HLA-B alleles were described. OBJECTIVES: To investigate genetic association at a genome-wide level on a large sample of SJS/TEN patients. METHODS: We performed a genome wide association study on a sample of 424 European cases and 1,881 controls selected from a Reference Control Panel. RESULTS: Six SNPs located in the HLA region showed significant evidence for association (OR range: 1.53-1.74). The haplotype formed by their risk allele was more associated with the disease than any of the single SNPs and was even much stronger in patients exposed to allopurinol (OR(allopurinol )= 7.77, 95%CI = [4.66; 12.98]). The associated haplotype is in linkage disequilibrium with the HLA-B*5801 allele known to be associated with allopurinol induced SJS/TEN in Asian populations. CONCLUSION: The involvement of genetic variants located in the HLA region in SJS/TEN is confirmed in European samples, but no other locus reaches genome-wide statistical significance in this sample that is also the largest one collected so far. If some loci outside HLA play a role in SJS/TEN, their effect is thus likely to be very small.
format Online
Article
Text
id pubmed-3173287
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31732872011-09-15 Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe Génin, Emmanuelle Schumacher, Martin Roujeau, Jean-Claude Naldi, Luigi Liss, Yvonne Kazma, Rémi Sekula, Peggy Hovnanian, Alain Mockenhaupt, Maja Orphanet J Rare Dis Research BACKGROUND: Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but extremely severe cutaneous adverse drug reactions in which drug-specific associations with HLA-B alleles were described. OBJECTIVES: To investigate genetic association at a genome-wide level on a large sample of SJS/TEN patients. METHODS: We performed a genome wide association study on a sample of 424 European cases and 1,881 controls selected from a Reference Control Panel. RESULTS: Six SNPs located in the HLA region showed significant evidence for association (OR range: 1.53-1.74). The haplotype formed by their risk allele was more associated with the disease than any of the single SNPs and was even much stronger in patients exposed to allopurinol (OR(allopurinol )= 7.77, 95%CI = [4.66; 12.98]). The associated haplotype is in linkage disequilibrium with the HLA-B*5801 allele known to be associated with allopurinol induced SJS/TEN in Asian populations. CONCLUSION: The involvement of genetic variants located in the HLA region in SJS/TEN is confirmed in European samples, but no other locus reaches genome-wide statistical significance in this sample that is also the largest one collected so far. If some loci outside HLA play a role in SJS/TEN, their effect is thus likely to be very small. BioMed Central 2011-07-29 /pmc/articles/PMC3173287/ /pubmed/21801394 http://dx.doi.org/10.1186/1750-1172-6-52 Text en Copyright ©2011 Génin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Génin, Emmanuelle
Schumacher, Martin
Roujeau, Jean-Claude
Naldi, Luigi
Liss, Yvonne
Kazma, Rémi
Sekula, Peggy
Hovnanian, Alain
Mockenhaupt, Maja
Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
title Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
title_full Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
title_fullStr Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
title_full_unstemmed Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
title_short Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
title_sort genome-wide association study of stevens-johnson syndrome and toxic epidermal necrolysis in europe
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173287/
https://www.ncbi.nlm.nih.gov/pubmed/21801394
http://dx.doi.org/10.1186/1750-1172-6-52
work_keys_str_mv AT geninemmanuelle genomewideassociationstudyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisineurope
AT schumachermartin genomewideassociationstudyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisineurope
AT roujeaujeanclaude genomewideassociationstudyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisineurope
AT naldiluigi genomewideassociationstudyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisineurope
AT lissyvonne genomewideassociationstudyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisineurope
AT kazmaremi genomewideassociationstudyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisineurope
AT sekulapeggy genomewideassociationstudyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisineurope
AT hovnanianalain genomewideassociationstudyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisineurope
AT mockenhauptmaja genomewideassociationstudyofstevensjohnsonsyndromeandtoxicepidermalnecrolysisineurope